Vote Scores

Home / Companies / Enochian Biosciences Inc. / 21 Jul 2023

Meeting · year to 30 June 202438 filers reporting

Enochian Biosciences Inc.: meeting of 21 Jul 2023

Votes reported on Form N-PX, item by item

38 Form N-PX filers reported votes at the Enochian Biosciences Inc. meeting of 21 Jul 2023. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

7 nominees; 58.6% of reported votes for; 36 filers withheld from or voted against at least one nominee.

406 vote records from 37 filers. 2 of the 36 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

91.9% for0.0% against8.1% other5.6% against management37 filers
2

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

58 vote records from 37 filers. 0 of the 36 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

97.3% for0.0% against2.7% other0.0% against management37 filers100.0% for0.0% against0.0% against management666,930 reported shares
3

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

59 vote records from 38 filers. 3 of the 37 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

89.5% for7.9% against2.6% other8.1% against management38 filers99.7% for0.3% against0.3% against management667,793 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Auditor
VanguardForFor
BlackRock and iSharesForFor
FidelityForFor
DimensionalForFor
State Street and SPDRForFor
American CenturyForFor
EquitableForFor
Charles SchwabForFor
Nuveen and TIAAForFor
ProShares and ProFundsForFor
Morgan Stanley, Eaton Vance and CalvertAbstain or withhold *For
Northern Trust and FlexSharesForFor
T. Rowe PriceForFor
Lincoln FinancialForFor
NationwideForFor
Guggenheim and RydexForFor
PrincipalForFor
Pacific Life fundsForFor
DWSForFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Enochian Biosciences Inc. meeting?

38 Form N-PX filers reported votes at the meeting of 21 Jul 2023. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Enochian Biosciences Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Enochian Biosciences Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Enochian Biosciences Inc. with a meeting date within three days of 21 Jul 2023. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.